BCLI

BRAINSTORM CELL THERAPUTC

Delisted

BCLI was delisted on the 17th of July, 2025.

38 hedge funds and large institutions have $2.52M invested in BRAINSTORM CELL THERAPUTC in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

64% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 14

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$42K
Puts
$29K
Net Calls
Net Calls Change

Top Buyers

1 +$44.2K
2 +$12.2K
3 +$5.52K
4
Morgan Stanley
Morgan Stanley
New York
+$2.88K
5
JF
Jump Financial
Illinois
+$2.53K

Top Sellers

1 -$235K
2 -$30.5K
3 -$18.9K
4
VF
Virtu Financial
New York
-$17K
5
TRCT
Tower Research Capital (TRC)
New York
-$14.5K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.59M
2
$347K
3
$152K
4
$87K
5
$78K
6
$54K
7
$34K
8
$27K
9
$25.9K
10
$21.9K
11
$15.1K
12
$12.2K
13
$12.2K
14
$11.4K
15
$10.8K
16
$10.1K
17
$5.37K
18
$5K
19
$4.56K
20
$3.19K
21
$2.98K
22
$2.76K
23
$2.59K
24
$2.53K
25
$2.42K